De Latemse Apotheek
ActiveSummary
De Latemse Apotheek has been active since 2014 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €202,794 and a net result of €467,955. Equity has been growing by about 9.1% per year since 2018. Its solvency ranks better than 25% of 12,781 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.5% (very low).
Overview
Official details
Source: KBO- Status
- Active since 18-01-2014 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730
- Joint committee
- 313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2025
- Establishment unit
- 2.226.959.751 9831 Sint-Martens-Latem, since 18-01-2014
- Financial year end
- 31 December
- Peppol
- Reachable since 19-12-2025
Board and ownership
- VERO CONSULT BVDirector · since 08-04-2021
- VEROPHAR HOLDING BVDirector · since 08-04-2021
- VEROPHAR HOLDING100%2025 annual accounts of VEROPHAR HOLDING
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.5%
- Gross margin
- €945,247
- ▲ 13.5%
- Turnover
- ≈ €3.4m
- estimated
- Profit
- €467,955
- ▲ 10.5%
- Equity
- €202,794
- ▲ 0.5%
- Total assets
- €1.4m
- ▲ 0.2%
- Employees on 31-12-2025
- 5
- =
Score breakdownraises riskEquity €202,794 (14.1% of total assets)Sector: Retail trade (NACE 47)lowers riskFigures for financial year 2025 (filed on 02-07-2026)Founded in 2014Show the evidence
Checked score
About 5 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 30% of them on solvency, 23% on liquidity, 96% on profitability and 41% on growth.
The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 9 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Key points
Recent changes
- · Gazette deed Registered office moved from Sint-Martens-Latem to DeurleNew seat: Klapstraat 2, 9831 Deurle · Previous seat: Pontstraat 40, 9831 Sint-Martens-Latem · Permanent representative: Thierry Vandeghinste
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as De Latemse Apotheek: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.3m and €2.1m, founded between 2012 and 2016.
| Company | Total assets | Gross margin |
|---|---|---|
| De Latemse Apotheek Sint-Martens-Latem | €1.4m | €0.9m |
| PHARMACIE VLEURGAT Brussel | €1.5m | €0.7m |
| Pharmacie Hasey-De Coninck Beaumont | €1.6m | €0.6m |
| PHARMA POSITIVE Sint-Lambrechts-Woluwe | €2.1m | €0.9m |
| PHARMACIE DENAMUR Viroinval | €1.5m | €0.6m |
| PHARMACIE DU TRIOMPHE Watermaal-Bosvoorde | €2.0m | €0.9m |
| Centrumapotheek Vosselaar Vosselaar | €1.3m | €0.6m |
Key facts about De Latemse Apotheek
- What is the company number of De Latemse Apotheek?
- The company number of De Latemse Apotheek is 0544.640.944. The VAT number is the same number with BE in front: BE 0544.640.944.
- Where is De Latemse Apotheek based?
- The registered office is at Klapstraat 2, 9831 Sint-Martens-Latem.Company details
- What does De Latemse Apotheek do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of De Latemse Apotheek?
- The legal form of De Latemse Apotheek is Private limited company (pre-2019) (BVBA).
- When was De Latemse Apotheek founded?
- De Latemse Apotheek was founded on 18-01-2014.
- Is De Latemse Apotheek still active?
- Yes, De Latemse Apotheek is an active enterprise in the KBO register.
- How many employees does De Latemse Apotheek have?
- De Latemse Apotheek had an average of 4.5 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does De Latemse Apotheek fall under?
- In its 2025 annual accounts, De Latemse Apotheek states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
- What is the turnover of De Latemse Apotheek?
- The turnover in financial year 2025 is ≈ €3.4m. This figure is estimated from the gross margin of €945,247 and 47 comparable companies (NACE 477). It probably lies between €2.7m and €5.7m.
- Is De Latemse Apotheek profitable?
- In financial year 2025, De Latemse Apotheek made a profit of €467,955.
- Where can I find the annual accounts of De Latemse Apotheek?
- De Latemse Apotheek filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of De Latemse Apotheek due?
- De Latemse Apotheek must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.